MedTrace Logo

Renal Denervation for the Treatment of Hypertension: A Pilot Safety and Efficacy Study

NCT02672462 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-02-04

No results posted yet for this study

Summary

A single center, self-controlled pilot study on safety and efficacy of renal denervation in treatment of hypertension.

Conditions

Interventions

DEVICE

Radio frequency renal denervation system (Golden Leaf GL-06E15A)

Sponsors & Collaborators

  • Shanghai Golden Leaf MedTec Co. Ltd

    lead INDUSTRY

Principal Investigators

  • Gengshan Ma, MD · Cardiovascular division, Dept. of Internal Medicine, Zhongda Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02672462 on ClinicalTrials.gov